Canada’s patent ‘utility’ regime on trial: Adrienne Blanchard for the MLI IP newsletter
The Supreme Court’s decision to hear AstraZeneca’s appeal and this month’s NAFTA hearings on an Eli Lilly complaint shine a ...
Tag: IP newsletter
Dodged bullet or missed opportunity with CHEO settlement?: Richard Owens for the MLI IP newsletter
While there was certainly a win on the costs of genetic testing, the long-term effects of Transgenomic’s departure from the ...
Stop the TPP-IP media pile-on: Richard Owens for the MLI IP newsletter
It has become fashionable to declare the Trans-Pacific Partnership intellectual property provisions a disaster for innovation in Canada, writes Richard ...
-
Canada’s conservatives care about freedom—except in health care: Shawn Whatley in the Hub
-
Government subsidies for Canada’s media were supposed to be temporary, but they keep on growing—and could be here to stay: Dave Snow in The Hub
-
Northern corridors: Hype or hope? Heather Exner-Pirot
-
Rushing to death in Canada’s MAiD regime: Ramona Coelho for Inside Policy
-
‘One China’ second thoughts: Why Canada must support Taiwan’s resilience
